نتائج البحث

Urologic Cancer Drug Costs in Low- and Middle-Income Countries

• Authors : Lan Anh S. Galloway; Brian D. Cortese; Ruchika Talwar

Subjects: drug costs; LMICs; novel hormonal therapy

• Source: Société Internationale d’Urologie Journal, Vol 5, Iss 5, Pp 312-319 (2024)

تفاصيل العنوان

Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act.

• Authors : Narasimmaraj, Prihatha; Oseran, Andrew; Tale, Archana

Subjects: Medicare; Part D; cardiovascular disease

• Source: Journal of the American College of Cardiology. 81(15)

تفاصيل العنوان

Treatment sequences and drug costs from diagnosis to death in multiple myeloma

• Authors : Seefat, M. R.; Cucchi, D. G.J.; Groen, K.

Subjects: article

• Source: Seefat , M R , Cucchi , D G J , Groen , K , Donker , M L , van der Hem , K G , Westerman , M , Gerrits , A M , Beeker , A , van de Donk , N W C J , Blommestein , H M & Zweegman , S 2024 , ' Treatment

تفاصيل العنوان

The Cost of Influence: How Gifts to Physicians Shape Prescriptions and Drug Costs

• Authors : Newham, Melissa; Valente, Marica

Subjects: Economics - General Economics

تفاصيل العنوان

Drug costs in context: assessing drug costs in cost-of-illness analyses

• Authors : T Joseph Mattingly II; Shannon Weathers

Subjects: burden-of-illness; cost-of-illness; drug costs

• Source: Drugs in Context, Vol 11, Pp 1-7 (2022)

تفاصيل العنوان

Exploring patient perspectives on the impact of resuming cost sharing: a qualitative analysis.

• Authors : Tran SHN; Department of Psychology, University of Waterloo, Waterloo, ON, Canada.; Department of Medicine, Cumming School of Medicine, University of Calgary, and Wellness Building 3E33, 3280 Hospital Dr. NW, TeachingCalgary, AB, Research, T2N 4Z6, Canada.

Subjects: Qualitative Research* ; Cost Sharing* ; Interviews as Topic*

• Source: Trials [Trials] 2024 Nov 09; Vol. 25 (1), pp. 749. Date of Electronic Publication: 2024 Nov 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis

• Authors : Ruilin Wang; Xinya Li; Xinchun Gu

Subjects: interrupted time series; zero markup drug policy; Parkinson's disease

• Source: Frontiers in Public Health, Vol 11 (2023)

تفاصيل العنوان

Decreasing drug waste, reducing drug costs, and improving workflow efficiency through the implementation of automated chemotherapy dose rounding rules in the electronic health record system.

• Authors : Shah V; Department of Pharmacy, Mayo Clinic, Phoenix, AZ, USA.; Spence A

Subjects: Antineoplastic Agents* ; Drug Costs*; Cost Savings

• Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2022 Apr 01; Vol. 79 (8), pp. 676-682.Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

What will it take for an injectable ARV to change the face of the HIV epidemic in high-prevalence countries? Considerations regarding drug costs and operations.

• Authors : Meyer-Rath G; Health Economics and Epidemiology Research Office (HE2RO), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/epidemiology ; HIV Infections*/HIV Infections*/HIV Infections*/prevention & control

• Source: Journal of the International AIDS Society [J Int AIDS Soc] 2023 Jul; Vol. 26 Suppl 2, pp. e26106.Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Access to essential and innovative anti-cancer medicines: a longitudinal study in Nanjing, China.

• Authors : Cao Z; School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.; Nanjing City Qixia District Hospital, Nanjing, Jiangsu, 210046, China.

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/economics ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/supply & distribution

• Source: BMC health services research [BMC Health Serv Res] 2024 Jul 11; Vol. 24 (1), pp. 802. Date of Electronic Publication: 2024 Jul 11.Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963

تفاصيل العنوان